论文标题
基于MRI的材料质量密度和通过深度学习的质子治疗相对停止功率估计
MRI-based Material Mass Density and Relative Stopping Power Estimation via Deep Learning for Proton Therapy
论文作者
论文摘要
磁共振成像(MRI)越来越多地纳入治疗计划中,因为它用于肿瘤和软组织描绘与计算机断层扫描(CT)的优质软组织对比度。但是,MRI不能直接提供质子放射疗法剂量计算所需的质量密度或相对停止功率(RSP)图。为了证明使用深度学习(DL)对质子放疗的可行性和RSP估计的可行性。开发了基于DL的框架,以发现MR图像与质量密度和RSP之间的基本体素相关性。根据ICRP报告中的材料组成信息,定制了五个组织替代幻象,包括皮肤,肌肉,脂肪,45%羟基磷灰石(HA)和Spongiosa骨骼。准备了由猪脑和肝脏制成的两个动物组织幻象进行DL训练。在幻影研究中,训练了两个DL模型:一个含有临床T1和T2 MRI的DL模型,另一个含有零回波时间(ZTE)MRI作为输入。在患者申请研究中,培训了两个DL模型:一种包括T1和T2 MRI作为输入,另一个包括合成双能计算机断层扫描(SDECT)图像以提供骨组织信息。 In the phantom study, DL model based on T1 and T2 MRI demonstrated higher accuracy mass density and RSP estimation in skin, muscle, adipose, brain, and liver with mean absolute percentage errors (MAPE) of 0.42%, 0.14%, 0.19%, 0.78% and 0.26% for mass density and 0.30%, 0.11%, 0.16%, 0.61% and 0.23% for RSP, respectively.纳入ZTE MRI的DL模型提高了45%HA和SPONGIOSA骨的质量密度和RSP估计的准确性,MAPE为0.23%,RSP分别为0.23%和0.09%和0.19%和0.07%。结果表明,使用DL方法对基于MRI的质量密度和RSP估计的可行性。
Magnetic Resonance Imaging (MRI) is increasingly incorporated into treatment planning, because of its superior soft tissue contrast used for tumor and soft tissue delineation versus computed tomography (CT). However, MRI cannot directly provide mass density or relative stopping power (RSP) maps required for proton radiotherapy dose calculation. To demonstrate the feasibility of MRI-only based mass density and RSP estimation using deep learning (DL) for proton radiotherapy. A DL-based framework was developed to discover underlying voxel-wise correlation between MR images and mass density and RSP. Five tissue substitute phantoms including skin, muscle, adipose, 45% hydroxyapatite (HA), and spongiosa bone were customized for MRI scanning based on material composition information from ICRP reports. Two animal tissue phantoms made of pig brain and liver were prepared for DL training. In the phantom study, two DL models were trained: one containing clinical T1 and T2 MRIs and another incorporating zero echo time (ZTE) MRIs as input. In the patient application study, two DL models were trained: one including T1 and T2 MRIs as input, and one incorporating synthetic dual-energy computed tomography (sDECT) images to provide bone tissue information. In the phantom study, DL model based on T1 and T2 MRI demonstrated higher accuracy mass density and RSP estimation in skin, muscle, adipose, brain, and liver with mean absolute percentage errors (MAPE) of 0.42%, 0.14%, 0.19%, 0.78% and 0.26% for mass density and 0.30%, 0.11%, 0.16%, 0.61% and 0.23% for RSP, respectively. DL model incorporating ZTE MRI improved the accuracy of mass density and RSP estimation in 45% HA and spongiosa bone with MAPE at 0.23% and 0.09% for mass density and 0.19% and 0.07% for RSP, respectively. Results show feasibility of MRI-only based mass density and RSP estimation for proton therapy treatment planning using DL method.